176 related articles for article (PubMed ID: 31560858)
1. Ceruloplasmin deficiency does not induce macrophagic iron overload: lessons from a new rat model of hereditary aceruloplasminemia.
Kenawi M; Rouger E; Island ML; Leroyer P; Robin F; Rémy S; Tesson L; Anegon I; Nay K; Derbré F; Brissot P; Ropert M; Cavey T; Loréal O
FASEB J; 2019 Dec; 33(12):13492-13502. PubMed ID: 31560858
[TBL] [Abstract][Full Text] [Related]
2. [Aceruloplasminemia, a rare condition not to be overlooked].
Lobbes H; Reynaud Q; Mainbourg S; Lega JC; Durieu I; Durupt S
Rev Med Interne; 2020 Nov; 41(11):769-775. PubMed ID: 32682623
[TBL] [Abstract][Full Text] [Related]
3. Novel ceruloplasmin mutation causing aceruloplasminemia with hepatic iron overload and diabetes without neurological symptoms.
Rusticeanu M; Zimmer V; Schleithoff L; Wonney K; Viera J; Zimmer A; Hübschen U; Bohle RM; Grünhage F; Lammert F
Clin Genet; 2014 Mar; 85(3):300-1. PubMed ID: 23557349
[No Abstract] [Full Text] [Related]
4. Genetic and Clinical Heterogeneity in Thirteen New Cases with Aceruloplasminemia. Atypical Anemia as a Clue for an Early Diagnosis.
Vila Cuenca M; Marchi G; Barqué A; Esteban-Jurado C; Marchetto A; Giorgetti A; Chelban V; Houlden H; Wood NW; Piubelli C; Dorigatti Borges M; Martins de Albuquerque D; Yotsumoto Fertrin K; Jové-Buxeda E; Sanchez-Delgado J; Baena-Díez N; Burnyte B; Utkus A; Busti F; Kaubrys G; Suku E; Kowalczyk K; Karaszewski B; Porter JB; Pollard S; Eleftheriou P; Bignell P; Girelli D; Sanchez M
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235485
[TBL] [Abstract][Full Text] [Related]
5. Does aceruloplasminemia modulate iron phenotype in thalassemia intermedia?
Pelucchi S; Pelloni I; Arosio C; Mariani R; Piperno A
Blood Cells Mol Dis; 2016 Mar; 57():112-4. PubMed ID: 26777753
[No Abstract] [Full Text] [Related]
6. Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation.
Finkenstedt A; Wolf E; Höfner E; Gasser BI; Bösch S; Bakry R; Creus M; Kremser C; Schocke M; Theurl M; Moser P; Schranz M; Bonn G; Poewe W; Vogel W; Janecke AR; Zoller H
J Hepatol; 2010 Dec; 53(6):1101-7. PubMed ID: 20801540
[TBL] [Abstract][Full Text] [Related]
7. Aceruloplasminemia: an update.
Kono S
Int Rev Neurobiol; 2013; 110():125-51. PubMed ID: 24209437
[TBL] [Abstract][Full Text] [Related]
8. Aceruloplasminemia.
Kono S
Curr Drug Targets; 2012 Aug; 13(9):1190-9. PubMed ID: 22515740
[TBL] [Abstract][Full Text] [Related]
9. Spleen iron, molybdenum, and manganese concentrations are coregulated in hepcidin-deficient and secondary iron overload models in mice.
Cavey T; Latour C; Island ML; Leroyer P; Guggenbuhl P; Coppin H; Roth MP; Bendavid C; Brissot P; Ropert M; Loréal O
FASEB J; 2019 Oct; 33(10):11072-11081. PubMed ID: 31298936
[TBL] [Abstract][Full Text] [Related]
10. Aceruloplasminemia.
Miyajima H
Neuropathology; 2015 Feb; 35(1):83-90. PubMed ID: 25168455
[TBL] [Abstract][Full Text] [Related]
11. The copper-iron connection: hereditary aceruloplasminemia.
Nittis T; Gitlin JD
Semin Hematol; 2002 Oct; 39(4):282-9. PubMed ID: 12382203
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of heterozygosis for aceruloplasminemia.
Borges MD; de Albuquerque DM; Lanaro C; Costa FF; Fertrin KY
Am J Med Genet B Neuropsychiatr Genet; 2019 Jun; 180(4):266-271. PubMed ID: 30901137
[TBL] [Abstract][Full Text] [Related]
13. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis.
Xu X; Pin S; Gathinji M; Fuchs R; Harris ZL
Ann N Y Acad Sci; 2004 Mar; 1012():299-305. PubMed ID: 15105274
[TBL] [Abstract][Full Text] [Related]
14. Quantitative evaluation of expression of iron-metabolism genes in ceruloplasmin-deficient mice.
Yamamoto K; Yoshida K; Miyagoe Y; Ishikawa A; Hanaoka K; Nomoto S; Kaneko K; Ikeda S; Takeda S
Biochim Biophys Acta; 2002 Dec; 1588(3):195-202. PubMed ID: 12393173
[TBL] [Abstract][Full Text] [Related]
15. Hepatic iron overload associated with a decreased serum ceruloplasmin level in a novel clinical type of aceruloplasminemia.
Kono S; Suzuki H; Takahashi K; Takahashi Y; Shirakawa K; Murakawa Y; Yamaguchi S; Miyajima H
Gastroenterology; 2006 Jul; 131(1):240-5. PubMed ID: 16831606
[TBL] [Abstract][Full Text] [Related]
16. Central nervous system involvement in a rare genetic iron overload disorder.
Bethlehem C; van Harten B; Hoogendoorn M
Neth J Med; 2010 Oct; 68(10):316-8. PubMed ID: 21071777
[TBL] [Abstract][Full Text] [Related]
17. Seizures in Hereditary Aceruloplasminemia.
Marano M; Bove F; Ricci L; Rohani M; Di Lazzaro V; Assenza G; Fasano A
Can J Neurol Sci; 2021 Jan; 48(1):144-147. PubMed ID: 32741407
[No Abstract] [Full Text] [Related]
18. Molecular and pathological basis of aceruloplasminemia.
Kono S; Miyajima H
Biol Res; 2006; 39(1):15-23. PubMed ID: 16629161
[TBL] [Abstract][Full Text] [Related]
19. Teaching NeuroImages: neurodegeneration with brain iron accumulation in aceruloplasminemia.
Parks NE; Vandorpe RA; Moeller JJ
Neurology; 2013 Nov; 81(20):e151-2. PubMed ID: 24218322
[TBL] [Abstract][Full Text] [Related]
20. Iron metabolism and related genetic diseases: A cleared land, keeping mysteries.
Brissot P; Loréal O
J Hepatol; 2016 Feb; 64(2):505-515. PubMed ID: 26596411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
